buthionine sulfoximine has been researched along with paclitaxel in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Cook, JA; Hahn, SM; Kaufman, DC; Liebmann, JE; Lipschultz, C; Mitchell, JB | 1 |
| Parekh, H; Simpkins, H | 1 |
| Baguley, BC; Davey, MW; Davey, RA; Hargrave, RM; Harvie, RM; Su, GM | 1 |
| Crowe, A | 1 |
| Burger, RA; Fruehauf, JP; Monk, BJ; Parker, R; Radany, EH; Redpath, L | 1 |
| Assreuy, J; Freitas, MS; Santos-Silva, MC | 1 |
| Bozzi, A; Brisdelli, F; Ferretti, A; Iorio, E; Knijn, A; Marcheggiani, D | 1 |
| Aykin-Burns, N; Coleman, MC; Hadzic, T; Jacobson, GM; Leick, K; Spitz, DR; Zhu, Y | 1 |
| Berger, T; Cappello, P; Cescon, DW; Chu, MF; Duncan, G; Garcia-Valero, M; Gorrini, C; Hodgson, K; Jafari, SM; Mak, TW; McGaha, TL; Palomero, L; Pujana, MA; Roux, C; Shinde, R; Silvester, J; Wakeham, A | 1 |
11 other study(ies) available for buthionine sulfoximine and paclitaxel
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Topics: Buthionine Sulfoximine; Cell Cycle; Cell Survival; Female; Fluorescent Antibody Technique; Glutathione; Humans; In Vitro Techniques; Methionine Sulfoximine; Microtubules; Paclitaxel; Tumor Cells, Cultured | 1993 |
Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Cell Survival; Cisplatin; Colchicine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Glutathione; Humans; Lymphoma; Methionine Sulfoximine; Mitosis; Ovarian Neoplasms; Paclitaxel; Rats; Tumor Cells, Cultured; Verapamil; Vinca Alkaloids | 1996 |
The potential of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide to circumvent three multidrug-resistance phenotypes in vitro.
Topics: Acridines; Amsacrine; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Cell Line; Cell Survival; Daunorubicin; Drug Resistance, Multiple; HL-60 Cells; Humans; Idarubicin; Leukemia; Paclitaxel; Phenotype; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Verapamil | 1997 |
The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel.
Topics: Analgesics, Opioid; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Buthionine Sulfoximine; Caco-2 Cells; Cyclosporine; Cyclosporins; Dose-Response Relationship, Drug; Genistein; Glutathione; Humans; Indomethacin; Morphine; Paclitaxel; Probenecid; Progesterone; Time Factors; Verapamil | 2002 |
Development of an in vitro chemo-radiation response assay for cervical carcinoma.
Topics: Antineoplastic Agents; Buthionine Sulfoximine; Carcinoma, Squamous Cell; Carmustine; Cell Division; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Drug Screening Assays, Antitumor; Female; Humans; Paclitaxel; Pilot Projects; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2002 |
Involvement of NF-kappaB and glutathione in cytotoxic effects of nitric oxide and taxol on human leukemia cells.
Topics: Buthionine Sulfoximine; Carmustine; Cell Line, Tumor; Glutathione; Humans; Leukemia; NF-kappa B; Nitric Oxide; Paclitaxel; Proline; S-Nitroso-N-Acetylpenicillamine; Thiocarbamates | 2006 |
Metabolic alterations in K562 cells exposed to taxol and tyrphostin AG957: 1H NMR and biochemical studies.
Topics: Antineoplastic Agents, Phytogenic; Buthionine Sulfoximine; Glutathione; Humans; Inositol; K562 Cells; Lipid Metabolism; Magnetic Resonance Spectroscopy; Models, Statistical; Paclitaxel; Phospholipids; Phosphorylcholine; Time Factors; Tyrphostins | 2005 |
Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress.
Topics: Breast Neoplasms; Buthionine Sulfoximine; Cell Survival; Deoxyglucose; Drug Synergism; Female; Fibroblasts; Glucose; Humans; Hydrogen Peroxide; Oxidative Stress; Paclitaxel; Reactive Oxygen Species; Tumor Cells, Cultured | 2010 |
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1.
Topics: Animals; B7-H1 Antigen; Breast Neoplasms; Buthionine Sulfoximine; Cell Line, Tumor; Chemokines; Drug Therapy; Female; Glutathione; Humans; Immunosuppressive Agents; Macrophages; Mice; Paclitaxel; Phenotype; Reactive Oxygen Species; RNA, Messenger; Triple Negative Breast Neoplasms; Tumor Microenvironment; Up-Regulation | 2019 |